Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Large Decrease in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX) was the recipient of a significant decline in short interest in January. As of January 15th, there was short interest totalling 111,600 shares, a decline of 60.6% from the December 31st total of 283,600 shares. Approximately 9.0% of the company’s stock are short sold. Based on an average trading volume of 831,600 shares, the days-to-cover ratio is currently 0.1 days.

Autonomix Medical Stock Down 2.4 %

Autonomix Medical stock traded down $0.08 during midday trading on Thursday, hitting $3.02. 53,870 shares of the company’s stock were exchanged, compared to its average volume of 368,096. The company has a debt-to-equity ratio of 0.36, a quick ratio of 4.26 and a current ratio of 4.26. The company has a market cap of $3.47 million and a PE ratio of -0.19. The firm has a 50-day moving average of $3.79 and a two-hundred day moving average of $10.69. Autonomix Medical has a 12 month low of $2.55 and a 12 month high of $121.80.

Autonomix Medical (NASDAQ:AMIX) last released its quarterly earnings data on Friday, November 8th. The company reported ($2.47) earnings per share (EPS) for the quarter. As a group, analysts expect that Autonomix Medical will post -10 earnings per share for the current fiscal year.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.